United Therapeutics Unveils Tresmi: The "Category Killer" Inhaler Set to End Coughing Woes in PAH and ILD

United Therapeutics announces Tresmi, a revolutionary soft mist inhaler version of Treprostinil that cuts coughing side effects by up to 90%. Planned approval filing this year and launch next year, impacting strategic partner MannKind's stock.